India's Emcure Pharma gains; JM bullish on domestic, export growth

Emcure Pharmaceuticals

04/08/2025 08:20

** Emcure Pharmaceuticals EMCU.NS rises 3.5% to 1.412 rupees

** JM Financial starts with "buy"; sets PT at 1,740 rupees, 27.5% upside to last close

** Expects revenue/EBITDA/PAT to grow at 13%/21%/29% CAGR over FY25–FY28, driven by domestic recovery, sustained export expansion

** Says new products in women's health, skin care, addition of Sanofi's medicines expected to boost growth

** Adds export business to benefit from complex generics, biosimilars, ARV markets across Europe, Canada, emerging economies

** YTD, ENCU falls 2.4%

 (Reporting by Rudra Pratap Singh in Bengaluru)

 ((rudrapratap.singh@thomsonreuters.com))